OIS (Ophthalmic Imaging Systems) gains interest from new investor
This article was originally published in Clinica
Executive Summary
S2 Partners, a Minnesota-based institutional investor, has purchased over half a million shares in Ophthalmic Imaging Systems (OIS) from MediVision, OIS' major shareholder. The 550,000 shares were bought at a price of $1.35 per share, $0.25 higher than the midpoint in OIS' trading range in the past year, according to a report by the Sacramento Business Journal.